Semaglutide vs. Tirzepatide: Weight Loss, Timelines, and Plateaus Compared
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) get compared constantly, usually around one question: which one works better? A large head-to-head trial has actually answered part of that directly — here's what it found, and what it does and doesn't tell you about plateaus specifically.
The head-to-head data
The SURMOUNT-5 trial directly compared the two medications in the same study population over 72 weeks, with participants on the maximum tolerated dose of either drug (tirzepatide 10 mg or 15 mg; semaglutide 1.7 mg or 2.4 mg). The results:
- Tirzepatide: average 20.2% body weight reduction (about 22.8 kg / 50 lb)
- Semaglutide: average 13.7% body weight reduction (about 15.0 kg / 33 lb)
Participants on tirzepatide were also more likely to reach higher weight-loss thresholds (10%, 15%, even 25% of body weight) than those on semaglutide. This was a well-designed, direct comparison — not just two separate trials being compared after the fact — so it's about as solid as this kind of data gets. See the trial summary.
What this doesn't tell you: these are group averages from a clinical trial, not a guarantee for any individual. Plenty of people lose more on semaglutide than the average, and plenty plateau earlier on tirzepatide than the average. Your own response depends on dose tolerance, consistency, and the same lifestyle factors that matter with any GLP-1 medication.
Why the mechanisms differ
Semaglutide acts on the GLP-1 receptor alone. Tirzepatide acts on both the GIP and GLP-1 receptors — a dual mechanism that's the leading explanation for its larger average effect in trials. For the full breakdown of each drug's mechanism and titration schedule, see our dedicated guides: semaglutide plateau guide and tirzepatide plateau guide.
Titration schedule, side by side
| Semaglutide (Wegovy) | Tirzepatide (Zepbound) |
|---|---|
| 0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg | 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg |
| ~16 weeks to reach maintenance dose | Up to ~20-24 weeks to reach the highest dose, depending on tolerability |
What this means for plateaus specifically
A bigger average total loss doesn't mean tirzepatide is immune to plateaus, or that semaglutide plateaus "worse" — both medications follow the same basic plateau dynamic once appetite suppression and calorie deficit stabilize. What differs is mostly timing: because tirzepatide's titration runs longer, an apparent slowdown earlier in treatment is more likely to just be titration rather than a genuine plateau. Once you're at a stable dose on either medication, the same troubleshooting checklist applies — see our full plateau-breaking guide, or run your own numbers through the Plateau Checker.
So which one should you choose?
That's a conversation for you and your prescriber, not something trial averages alone can answer. Side-effect tolerance (GI symptoms are commonly reported with both, though not identically), insurance coverage and cost, and which formulation your prescriber has experience with all matter as much as the average numbers above — sometimes more, since the medication that actually gets taken consistently outperforms the "better" one on paper.
Common questions
Can I switch from semaglutide to tirzepatide if I've plateaued?
Some people do switch after a prolonged plateau, and the SURMOUNT-5 data is part of why that conversation comes up. It's a decision to make with your prescriber, factoring in why you plateaued in the first place — a switch won't help if the underlying issue is something like inconsistent protein intake or sleep.
Is tirzepatide always the "better" choice since it showed more weight loss in trials?
Not necessarily for every individual. Group averages describe the trial population, not you specifically, and factors like side-effect tolerance and cost can outweigh a few percentage points of average difference in practice.
Does tirzepatide have worse side effects than semaglutide?
Both are associated with similar gastrointestinal side effects (nausea, constipation, diarrhea), and head-to-head safety data hasn't shown one to be clearly worse overall. Individual tolerance varies considerably.
Discussing your options with a provider?
A telehealth weight-management provider can help you weigh semaglutide vs. tirzepatide based on your own health history and coverage.
-
Ro — GLP-1 program with physician oversight Learn more
Ro's providers can prescribe either semaglutide or tirzepatide-based medications depending on what fits your health history, and offer ongoing messaging support if you're considering switching between them. Medication cost is billed separately from the membership and varies by drug and coverage.
-
Found — coaching + medical weight management Learn more
Found's clinicians work with more than 10 different medication options, including both semaglutide- and tirzepatide-based treatments, and can help weigh cost against the average differences covered above. Cash plans start around $169/month including compounded medication; brand-name options run considerably higher.
Advertising disclosure: Past The Plateau may earn a commission if you sign up through these links, at no extra cost to you. Pricing and coverage details change — confirm current terms directly on each provider's site.